Related Experiment Videos
Characterization of a bacteriocin from Staphylococcus aureus strain 462.
Antimicrobial Agents and Chemotherapy
|December 1, 1973
Summary
Researchers isolated Staphylococcus aureus 462, a bacteriocin-producing strain. Staphylococcin 462, primarily protein, was extracted from bacterial cells and purified, revealing its antimicrobial properties against Gram-positive bacteria.
Area of Science:
- Microbiology
- Biochemistry
Background:
- Bacteriocin production by Staphylococcus aureus strains of animal origin is a potential area for antimicrobial development.
- Staphylococcus aureus 462 was identified as one of three bacteriocin-producing strains from 200 animal isolates.
Purpose of the Study:
- To characterize the bacteriocin produced by Staphylococcus aureus 462.
- To determine the extraction, purification, and molecular properties of staphylococcin 462.
Main Methods:
- Bacteriocin activity screening of staphylococcal isolates.
- Extraction using 7 M urea.
- Purification via gel permeation chromatography (Sephadex G-200) and preparative polyacrylamide gel electrophoresis (SDS-PAGE).
- Chemical analysis and molecular weight determination.
Main Results:
- Staphylococcin 462 exhibits specific antimicrobial activity against certain Staphylococcus aureus strains and other Gram-positive bacteria, but not Gram-negative organisms.
- The bacteriocin was not released into culture supernatant or released by mechanical cell disruption.
- Extraction with 7 M urea effectively liberated the bacteriocin activity.
- Purified staphylococcin 462 is composed of approximately 90% protein and 3% lipid, with a molecular weight of about 9,000 Da.
Conclusions:
- Staphylococcin 462 is an intracellular bacteriocin produced by Staphylococcus aureus 462.
- The purification and characterization provide insights into its biochemical nature and potential as a targeted antimicrobial agent.